Skip to content

Investigation of the effects of Tactile Care for mothers of children with developmental disorders

Investigating the effects of Tactile Care on reducing anxiety in mothers of children with developmental disorders - The anxiety-reducing effect of Tactile Care

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000057014
Enrollment
6
Registered
2025-02-15
Start date
2025-03-01
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mother of a child with developmental disabilities

Interventions

Intervention period: The therapist provide Tactile Care to the participant&#39
s back every other week. (for 3 months, 6 times) Non-intervention period: Participants sit quietly for 10 minutes every other week. (for 3 months, 6 times)

Sponsors

Kanon Matsuyama Co., Ltd, Matsuyama, Japan
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1.Participants are mothers of children with developmental disorders. (elementary and junior high school students) 2.Mothers can participate in the measurements. (every other week) 3.Participants can wear the measurement device on their wrists and install the app on their smartphones. (6 months) 4.Participants can have the therapist touch their back.

Exclusion criteria

Exclusion criteria: The exclusion criteria are as follows: pregnant or possibly pregnant, uncomfortable with being touched, no experience of bring up after a child with a developmental disorder, currently undergoing treatment for depression.

Design outcomes

Primary

MeasureTime frame
1.Tactile Care has an effect on physiological indicators such as body temperature, breathing, heart rate, time to fall asleep, and sleep time after the intervention.

Countries

Japan

Contacts

Public ContactChieko Takasuka

Kanon Matsuyama Co., Ltd, Matsuyama, Japan Davelopment of support room Dekopon

ruihimepom@gmail.com089-925-2525

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Sep 19, 2026